Company news

Avecho Biotechnology Limited news in 2025

Avecho Biotechnology Limited's news releases, calls and decks from 2025, newest first.

View company

Phase III CBD Clinical Trial Recruitment Update

December 17, 2025

AVE Secures US & EU Patent Allowances for CBD Soft-Gel

December 3, 2025

September 2025 Quarterly Activities Report & Appendix 4C

October 31, 2025

Avecho raises $2.5m via placement

October 22, 2025

Appendix 4D and Half-year Financial Report

August 28, 2025

Sleep Health Week: Researchers Recruiting Now for CBD Insomnia Trial

August 11, 2025

June 2025 Quarterly Activities Report & Appendix 4C

July 29, 2025

Phase III Insomnia Trial Recruitment Update

July 28, 2025

Receipt of R&D Tax Incentive

May 28, 2025

Phase III Trial Update - New Sites Commence Recruitment

May 19, 2025

March 2025 Quarterly Activities Report & Appendix 4C

April 30, 2025

Avecho receives initial US$3M upfront payment from Sandoz

March 27, 2025

Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia

March 3, 2025

Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS

March 2, 2025

Trading Halt

February 27, 2025

Appendix 4E - Preliminary Final Report

February 27, 2025

Response to ASX Price Query

February 14, 2025

December 2024 Quarterly Activities Report & Appendix 4C

January 30, 2025

Decks in 2025